Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 12, 2020
Does primary tumor localization has prognostic importance in seminoma patients?: Turkish Oncology Group StudyBirol Yildiz, Ahmet Kucukarda, Ali Gokyer, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?Birol Ocak, Ahmet Bilgehan Sahin, Ismail Ertürk, et al.
Therapeutic Advances in Medical Oncology|September 3, 2025
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective studyOgur Karhan, Serdar İleri, Zuhat Urakçı, et al.
Clinical Medicine Insights. Oncology|May 14, 2026
Prognostic Impact and Clinicopathological Correlates of HER2 Status in Gastric Cancer: A Multicenter Retrospective Turkish Oncology Group StudySedat Yildirim, Ozlem Nuray Sever, Ezgi Turkoglu, et al.
Clinical Genitourinary Cancer|April 16, 2024
Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)Hatime Arzu Yasar, Burak Yasin Aktas, Gokhan Ucar, et al.
Journal of Geriatric Oncology|September 8, 2023
PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG studyOkan Avcı, Yakup İriağaç, Eyyüp Çavdar, et al.
International Journal of Cancer|August 6, 2026
Diabetes Increases Immunotherapy-Related Toxicity but Not Efficacy in Metastatic Non-Small Cell Lung Cancer: A Multicenter Retrospective StudyEmre Çakır, Didem Divriklioğlu, Deniz Can Güven, et al.
Expert Review of Anticancer Therapy|January 9, 2026
Impact of renin-angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non-small cell lung cancerEmel Mutlu Ozkan, Ibrahim Karadağ, Elif Sahın, et al.
Molecular and Clinical Oncology|April 29, 2025
Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective studyAlpaslan Ozgun, Fatma Nihan Akkoc Mustafayev, Izzet Dogan, et al.
Breast Cancer Research and Treatment|August 9, 2024
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG studyİsmail Beypınar, Hacer Demir, Şendağ Yaslıkaya, et al.
Pageof 6